Browse > Article
http://dx.doi.org/10.3345/kjp.2010.53.1.41

Serum interleukin-6, tumor necrosis factor-α and adiponectin levels in Kawasaki disease  

An, Jung (Department of Pediatrics, Ewha Womans University, School of Medicine)
Kim, Han Gyu (Department of Pediatrics, Ewha Womans University, School of Medicine)
Sohn, Sejung (Department of Pediatrics, Ewha Womans University, School of Medicine)
Hong, Young Mi (Department of Pediatrics, Ewha Womans University, School of Medicine)
Publication Information
Clinical and Experimental Pediatrics / v.53, no.1, 2010 , pp. 41-47 More about this Journal
Abstract
Purpose : Adiponectin is an endogenous modulator of vascular remodeling that suppresses vascular inflammation. However, the role of adiponectin in Kawasaki disease (KD) has not been elucidated. The purpose of this study is to investigate the correlation between serum adiponectin level and several parameters, such as interleukin (IL)-6, tumor necrosis factor $(TNF)-{\alpha}$, lipid profile, and C reactive protein (CRP), and to clarify the association between adiponectin and cardiac function. Methods : Twenty-two KD patients (22 patients in acute phase and 20 patients in subacute phase) were enrolled in the study group. The control group consisted of 31 subjects (13 febrile patients and 18 healthy children). Both groups underwent blood sampling and tissue Doppler imaging (TDI). Results : CRP was significantly increased in the KD group compared with the control group. There were no significant differences in serum $TNF-{\alpha}$, IL-6, and adiponectin levels between groups. However, a negative correlation was found between adiponectin level and CRP level or platelet count. Systolic myocardial velocity and A myocardial velocity measured by TDI were decreased significantly in the acute KD group compared with the subacute KD group and control group. Positive correlations were found between adiponectin level and systolic myocardial velocity or A myocardial velocity. Conclusion : In acute KD patients, low adiponectin level was related to severe inflammatory reactions and decreased left ventricular functions.
Keywords
Kawasaki disease; Adiponectin; Echocardiography;
Citations & Related Records
연도 인용수 순위
  • Reference
1 Xu WJ, Gao Z, Li QS, Li CR, Zhao CY. Non-dilated coronary artery lesion and myocardial perfusion in children with Kawasaki disease: analysis of 43 cases. Zhonghua Er Ke Za Zhi 2004;42:613-6   PUBMED
2 Takeuchi D, Saji T, Takatsuki S, Fufwara M. Abnormal tissue doppler images are associated with elevated plasma brain nariuretic peptide and increased oxidatve stress in acute Kawasaki disease. Circ J 2007;71:357-62   DOI   ScienceOn
3 Shibata R, Izumiya Y, Sato K, Papanicolaou K, Kihara S, Colucci WS, et al. Adiponectin protects against the development of systolic dysfunction following myocardial infarction. J Mol Cell Cardiol 2007;42:1065-74   DOI   ScienceOn
4 Furuyama H, Odagawa Y, Katoh C, Iwado Y, Ito Y, Noriyasu K, et al. Altered myocardial flow reserve and endothelial function late after Kawasaki disease. J Pediatr 2003;142:149-54   DOI   ScienceOn
5 Burn JC, Kushner HI, Bastian JF, Shike H, Shimizu C, Matsubara T, et al. Kawasaki Disease: A Brief History. Pediatrics 2000;106:e27   DOI   PUBMED   ScienceOn
6 Ouchi N, Kihara S, Funahashi T, Matsuzawa Y, Walsh K. Obesity, adiponectin and vascular inflammatory disease. Curr Opin Lipidol 2003;14:561-6   DOI   ScienceOn
7 Brogan PA, Bose A, Burgner D, Shingadia D, Tulloh R, Michie C, et al. Kawasaki disease: an evidence based approach to diagnosis, treatment, and proposals for future research. Arch Dis Child 2002;86:286-90   DOI   ScienceOn
8 Keller P, Moller K, Krabbe KS, Pedersen BK. Circulating adiponectin levels during human endotoxaemia. Clin Exp Immunol 2003;134:107-10   DOI   PUBMED   ScienceOn
9 Landmesser U, Hornig B, Drexler H. Endothelial function: A critical determinant in atherosclerosis? Circulation 2004;109:1127-33   DOI   ScienceOn
10 Takeshita S, Takabayashi H, Yoshida N. Circulating adiponectin levels in Kawasaki disease. Acta Pediatr 2006;95:1312-4   DOI   ScienceOn
11 Donovan CL, Armstrong WF, Bach DS. Quantitatve doppler tissue imaging of the left ventricular myocardium: Validation in normal subjects. Am Heart J 1995;130:100-4   DOI   ScienceOn
12 Leung DY, Meissner HC, Fulton DR, Murray DL, Kotzin BL, Schlievert PM. Toxic shock syndrome toxin-secreting Staphylococcus aureus in Kawasaki syndrome. Lancet 1993;342:1385-8   DOI   ScienceOn
13 Newburger JW, Burns JC. Kawasaki disease. Vascular Med 1999;4:187-202   DOI
14 Suzuki A, Kamiya T, Kuwahara N, Ono Y, Kohata T, Takahashi O, et al. Coronary arterial lesions of Kawasaki disease: cardiac catheterization findings of 1,100 cases. Pediatr Cardiol 1986;7:3-9   DOI   ScienceOn
15 Yang WS, Lee WJ, Funahashi T, Tanaka S, Matsuzawa Y, Chao CL, et al. Plasma adiponectin levels in overweight and obese Asians. Obes Res 2002;10:1104-10   DOI   PUBMED   ScienceOn
16 Yamauchi T, Kamon J, Waki H, Terauchi t, Kubota N, Hara K, et al. The fat-derived hormone adiponectin reverses insulin resistance associated with both lipoatrophy and obesity. Nat Med 2001;7:941-6   DOI   ScienceOn
17 Masuda M, Shimomura I, Sata M, Arita Y, Nishida M, Maeda N, et al. Role of adiponectin in preventing vascular stenosis. The missing link of adipo-vascular axis. J Biol Chem 2002;277:37487-91   DOI   ScienceOn
18 Nagueh SF, Middleton KJ, Kopelen HA, Zoghbi WA, Quinones MA. Doppler tissue imaging: Noninvasive technique for evaluation of left ventricular diastolic function. J Am Coll Cardiol 1997;30:474-80   DOI   ScienceOn
19 Ouchi N, Ohishi M, Kihara S, Funahashi T, Nakamura T, Nagaretani H, et al. Association of hypoadiponectinemia with impaired vasoreactivity. Hypertension 2003;42:231-4   DOI   ScienceOn
20 Cavusoglu E, Chopra V, Battala V, Ruwende C, Yanamadala S, Eng C, et al. Baseline plasma adiponectin levels as a predictor of left ventricular systolic dysfunction in patient referred for coronary angiograpy. Am J Cardiol 2008;101:1073-8   DOI   ScienceOn
21 Berg AH, Scherer PE. Adipose tissue, inflammation, and cardiovascular disease. Circ Res 2005;96:939-49   DOI   ScienceOn
22 Okamoto Y, Arita Y, Nishida M, Maraguchi M, Ouchi N, Takahashi M, et al. An adipocyte-derived plasma protein, adiponectin, adheares to injured vascular walls. Horm Metab Res 2000;32:47-50   DOI   ScienceOn
23 Furukawa S, Matsubara T, Yone K, Hirano Y, Okumura K, Yabuta K. Kawasaki disease differs from anaphylactoid purpura and measles with regard to tumor necrosis factor-alpha and interleukin 6 in serum. Eur J Pediatr 1992;151:44-7   DOI   ScienceOn
24 Ogawa S, Ohkubo T, Fukazawa R, Kamisago M, Kuramochi Y, Uchikoba Y, et al. Estimation of myocardial hemodynamics before and after intervention in children with Kawasaki disease. J Am Coll Cardiol 2004;43:653-61   DOI   ScienceOn
25 Hauser M, Bengel F, Kuehn A, Nekolla S, Kaemmerer H, Schwaiger M, et al. Myocardial blood flow and coronary flow reserve in children with normal epicardial coronary arteries after the onset of Kawasaki disease assessed by positron emission tomography. Pediatr Cardiol 2004;25:108-12   DOI   ScienceOn
26 Kawasaki T, Kosaki F, Okawa S, Shigematsu I, Yanagawa H. A new infantile acute febrile mucocutaneous lymph node syndrome (MCLS) prevailing in Japan. Pediatrics 1974;54:271-6   PUBMED   ScienceOn
27 Yamauchi T, Kamon J, Waki H, Imai Y, Shimozawa N, Hioki K, et al. Globular adponectin protected ob/ob mice from diabetes and apoE deficient mice from atherosclerosis. J Biol Chem 2002;278:2641-8
28 Kato H, Sugimura T, Akagi T, Sato N, Hashino K, Maeno Y, et al. Long-term consequences of Kawasaki disease. A 10-to 21- year follow-up study of 594 patients. Circulation 1996;94:1379-85   PUBMED   ScienceOn
29 Burns JC, Glode MP. Kawasaki syndrome. Lancet 2004;364:533-44   DOI   ScienceOn